CN:002099 / Zhejiang Hisoar Pharmaceutical Co., Ltd. - Institutionelt ejerskab - Købere

Zhejiang Hisoar Pharmaceutical Co., Ltd.
CN ˙ SZSE ˙ CNE000001PY2
6,39 CN¥ ↓ -0,10 (-1,54%)
2025-09-12
DEL PRIS
Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Zhejiang Hisoar Pharmaceutical Co., Ltd., omfatter .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2025-08-26 NP FLCH - Franklin FTSE China ETF 9.200 12,20 7 40,00
2025-08-28 NP SPEM - SPDR(R) Portfolio Emerging Markets ETF This fund is a listed as child fund of State Street Corp and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 273.900 4,78 210 16,67
2025-06-26 NP DFEM - Dimensional Emerging Markets Core Equity 2 ETF 138.800 107,47 95 111,11
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista